Pharmaceutical composition for treating prostate cancer
US2017189416A1
Pharmaceutical composition for treating breast cancer
US2017189417A1
Pharmaceutical composition for treating colorectal cancer
US2017189418A1
Pharmaceutical composition for treating lung cancer
TW201705947A
Pharmaceutical composition for treating individual suffering from cancer comprising at least a pharmaceutically effective amount of a novel target liver cancer reversal signal substance, and a pharmaceutically acceptable supporting agent, a carrier, a diluent or an excipient
US2017036986A1
Method for extracting active principles from antrodia camphorata